dactinomycin has been researched along with tetraethylammonium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
| Fiumelli, H; Jabaudon, D; Magistretti, PJ; Martin, JL | 1 |
| Annunziato, L; Calì, G; Pannaccione, A; Scorziello, A; Secondo, A; Taglialatela, M | 1 |
3 other study(ies) available for dactinomycin and tetraethylammonium
| Article | Year |
|---|---|
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
BDNF stimulates expression, activity and release of tissue-type plasminogen activator in mouse cortical neurons.
Topics: Animals; Blotting, Northern; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Chelating Agents; Cycloheximide; Dactinomycin; DNA Primers; Egtazic Acid; Gene Expression; Mice; Nerve Growth Factors; Neuronal Plasticity; Neurons; Neuropeptides; Neuroserpin; Neurotrophin 3; Plasminogen Activator Inhibitor 1; Plasminogen Activator Inhibitor 2; Potassium; Protein Synthesis Inhibitors; RNA, Messenger; Serine Proteinase Inhibitors; Serpins; Tetraethylammonium | 1999 |
Nuclear factor-kappaB activation by reactive oxygen species mediates voltage-gated K+ current enhancement by neurotoxic beta-amyloid peptides in nerve growth factor-differentiated PC-12 cells and hippocampal neurones.
Topics: 4-Aminopyridine; Actin Cytoskeleton; Amyloid beta-Peptides; Animals; Blotting, Western; Calcium; Cell Differentiation; Cells, Cultured; Charybdotoxin; Chelating Agents; Cnidarian Venoms; Dactinomycin; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Electric Stimulation; Embryo, Mammalian; Enzyme Activation; Enzyme Inhibitors; GAP-43 Protein; Hippocampus; Membrane Potentials; Nerve Growth Factor; Neurons; NF-kappa B; Patch-Clamp Techniques; PC12 Cells; Peptide Fragments; Peptides; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Synthesis Inhibitors; Rats; Reactive Oxygen Species; Tetraethylammonium; Time Factors; Vitamin A | 2005 |